|I-29 Jonathan Mochel|
Using nonlinear mixed effects modeling to characterize the pharmacokinetics and pharmacodynamics of benazepril in dogs.
|I-38 Valerie Nock|
Comparison of three PK/PD models for glycated haemoglobin in diabetes type 2 patients treated with lixisenatide
|I-48 Kirill Peskov|
Mechanistic modeling approach relating human gut microbial community to physiologically-relevant biomarkers
|I-56 Christian Hove Claussen|
Pharmacokinetics of concentrated insulin mixtures: a biosimulation approach
|I-61 Rikke Meldgaard Røge|
Integrated model of glucose homeostasis including the effect of exogenous insulin
|III-04 Oskar Alskär|
Using allometric scaling on an integrated glucose insulin model for humans to investigate anti-diabetics drug effects in rats.
|III-20 Roberto Bizzotto|
Glucose Homeostasis Modeling: Improvement of the Insulin Action Component